A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer

Treatment of human epidermal growth factor receptor-2 (HER2)-positive breast cancer with dual anti-HER2 therapy has been shown to improve outcomes. In the present pilot phase II study, patients with early-stage HER2-positive breast cancer received adjuvant treatment with dose-dense paclitaxel, trast...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Breast Cancer
Main Authors: Iyengar, Neil M., Fornier, Monica N., Sugarman, Steven M., Theodoulou, Maria, Troso-Sandoval, Tiffany A., D’Andrea, Gabriella M., Drullinsky, Pamela R., Gajria, Devika, Goldfarb, Shari B., Comen, Elizabeth A., Lake, Diana E., Modi, Shanu, Traina, Tiffany A., Lacouture, Mario E., Chen, Melanie F., Patil, Sujata, Baselga, José, Norton, Larry, Hudis, Clifford A., Dang, Chau T.
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4968930/
https://ncbi.nlm.nih.gov/pubmed/26454612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2015.09.009
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker